Luke Moradi

Mr. Luke Moradi

UAB
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2021 in Uro
Verified
Journal Article
Open access
PDF file
HPHenry Paiste
Henry Paiste
Luke MoradiLuke Moradi
Luke Moradi
DADean G. Assimos
Dean G. Assimos
KWKyle D. Wood
Kyle D. Wood
Pankaj DanglePankaj Dangle
Pankaj Dangle
Objectives: To examine the most recent literature and published science in determining any and all possible associations between pediatric obesity and pediatric urolithiasis. Methods: Retrospective literature review of pediatric stone formers with diagnosed stone disease and all associated risk factors. Peer-reviewed, published manuscripts from the past several decades were analyzed for risk factors associated with pediatric obesity such as diet, hypertension, and renal diseases. Comparing the pediatric obesity literature with the pediatric stone forming literature, any associations and correlations were derived and analyzed. Results: Despite the existing evidence that obesity is linked to stones in adults, the evidence remains unclear whether obesity plays a role in children. Nutritional discrepancies, in the setting of the obesity epidemic, have been shown to alter the risk profile of pediatric patients. Consistent with the published literature, and lack of consistent correlation with obesity and stone disease, is the knowledge that age, gender, geography, and climate may all play a role in the onset of pediatric obesity and may also be on the causal pathway toward pediatric urolithiasis. Conclusion: The manuscript demonstrates that there are a number of risk factors, congenital or acquired, that are associated with pediatric obesity. The mechanisms responsible for these associations may be on the causal pathway toward childhood urolithiasis. These mechanisms that underlie these associations need to be further investigated.

2 June 2026 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
Luke MoradiLuke Moradi
Luke Moradi
RPRichard A. Popple
Richard A. Popple
RTRoman L. Travis
Roman L. Travis
SMSamuel R. Marcrom
Samuel R. Marcrom
KRKristen O. Riley
Kristen O. Riley
JFJohn B. Fiveash
John B. Fiveash
Radiosurgical treatment of multiple intracranial targets using a single isocenter is more efficient than sequential isocenter treatment. The primary concern with single-isocenter, multitarget (SIMT) stereotactic radiosurgery (SRS) is that rotational error may cause underdosing of peripheral lesions and/or increased normal tissue toxicity, particularly for targets distant from the isocenter. Many centers mitigate this risk by adding a planning target volume (PTV) margin, which increases dose to normal brain tissue. This study examined whether distance from the isocenter affects local tumor control or toxicity in patients treated with SIMT SRS using a 0 mm PTV margin. We retrospectively evaluated 429 patients with 3,039 intracranial tumors treated with SIMT SRS or fractionated SRS (fSRS) using single-isocenter volumetric modulated arc therapy (VMAT) plans with a 0 mm CTV/PTV expansion from GTV. All treatments used a Varian HD-120 MLC on a 6-degree-of-freedom couch. Local failure was defined as ≥25% increase in maximum tumor diameter (minimum 3 mm) or viable tumor cells at salvage surgery. Toxicity was defined as CTCAE v5.0 CNS grade ≥3. Of the 3039 tumors evaluated, 1510 and 1034 tumors had clinical and radiographic follow-up at 6-months and 1-year, respectively. Median distance from the isocenter was 4.9 cm (range 0.04 - 13.4 cm) and 70% of tumors in this study were ≥4 cm from the isocenter. 1-year local control was 95.1% (95% CI 94.0 - 96.1) and freedom from grade ≥3 toxicity was 98.4% (95% CI 97.8 - 99.0). Larger tumor volume correlated with both worse local control [HR 1.017 (95% CI 1.000-1.034), p = 0.047] and higher toxicity [HR 1.088 (95% CI 1.056-1.121), p < 0.001]. Increased distance from the isocenter was not associated with worse local failure or toxicity on multivariable analysis. In this retrospective analysis of SIMT VMAT radiosurgery using HD-120 MLC, 6-DOF couch, intrafraction surface monitoring, and 0 mm CTV/PTV margin, increased distance from the isocenter did not adversely impact short term local tumor control or increase high-grade toxicity. These findings are currently being tested in a prospective randomized trial.

25 October 2025 in Advances in Radiation Oncology
Verified
Journal Article
Open access
Luke MoradiLuke Moradi
Luke Moradi
RPRichard A. Popple
Richard A. Popple
RTRoman L. Travis
Roman L. Travis
SMSamuel R. Marcrom
Samuel R. Marcrom
KRKristen O. Riley
Kristen O. Riley
JFJohn B. Fiveash
John B. Fiveash
Single isocenter stereotactic radiosurgery (SRS) efficiently delivers radiation to patients with multiple brain metastases. Although several fractionated SRS (fSRS) regimens show acceptable local control and toxicity, few studies directly compare them. This retrospective study evaluates 2 common regimens—6 Gy × 5 fractions and 9 Gy × 3 fractions—for their effects on local control and toxicity. A retrospective review was conducted of 1215 brain tumors from 251 patients receiving either 9 Gy × 3 fx or 6 Gy × 5 fx fSRS. All tumors were treated with single isocenter volumetric modulated arc therapy. Recurrent tumors and postoperative cavities were excluded from the analysis. Local tumor failure was defined as 25% increase in maximum tumor diameter (minimum 3 mm) or more than scant tumor cells at time of salvage surgery. Toxicity included CTCAE V5.0 central nervous system (CNS) grade 3 or greater events. Local tumor control and freedom from toxicity were calculated using Kaplan–Meier method and Cox regression models. Overall local control was 93% at 1 year and 88% at 2 years. The 3-fraction regimen had superior 1-year local control compared with the 5-fraction regimen (97% vs. 91%, P = .001). Tumors <2 cm had significantly better control with 3 fractions (99% vs. 95%, P = .004), whereas tumors 2–4 cm showed no significant difference. One-year freedom from grade 3+ toxicity was similar between regimens (99% for 3-fx vs. 96% for 5-fx, P = .097). In this study, 9 Gy × 3 fx for brain metastases had improved tumor control and comparable toxicity to 6 Gy × 5, particularly among tumors <2 cm. 9 Gy × 3 fx may be the preferred regimen when treating multiple tumors with one prescription using single isocenter radiosurgery as it improves efficiency and local control while having similar toxicity.

16 November 2026 in Advances in Radiation Oncology
Verified
Journal Article
Open access
Luke MoradiLuke Moradi
Luke Moradi
PTPatrick J Trainor
Patrick J Trainor
RPRichard A Popple
Richard A Popple
RTRoman L Travis
Roman L Travis
SMSamuel R Marcrom
Samuel R Marcrom
JFJohn B Fiveash
John B Fiveash